These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21057904)

  • 21. Container Closure Integrity Testing-Method Development for Freeze-Dried Products Using Laser-Based Headspace Oxygen Analysis.
    Hede JO; Fosbøl PL; Berg SW; Dahl S
    PDA J Pharm Sci Technol; 2019; 73(2):170-180. PubMed ID: 30361284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Multicompany Survey Study for Helium Leak Container Closure Integrity Test.
    Mathaes R; Wuchner K; Riesop D; Wagner D; Dreher S; Woelfle F; Mudumala PR; Bonvin D; Müller C; Traub-Hoffmann K; Hebting H
    PDA J Pharm Sci Technol; 2022; 76(3):216-235. PubMed ID: 34782444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Container Closure System Integrity for Storage of Frozen Drug Products: Impact of Capping Force and Transportation.
    Nieto A; Roehl H; Adler M; Mohl S
    PDA J Pharm Sci Technol; 2018; 72(6):544-552. PubMed ID: 29853608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design control and validation of a facility for sterile clinical trial preparations.
    Staines L
    J Parenter Sci Technol; 1984; 38(3):109-14. PubMed ID: 6747778
    [No Abstract]   [Full Text] [Related]  

  • 25. Challenges for Cell-Based Medicinal Products From a Pharmaceutical Product Perspective.
    Jere D; Sediq AS; Huwyler J; Vollrath I; Kardorff M; Mahler HC
    J Pharm Sci; 2021 May; 110(5):1900-1908. PubMed ID: 33307042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Research on the relationship between cephalosporin structure, solution clarity, and rubber closure compatibility using volatile components profile of butyl rubber closures.
    Chong XM; Dong X; Yao SC; Hu CQ
    Drug Dev Ind Pharm; 2019 Jan; 45(1):159-167. PubMed ID: 30231654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of rubber closures with powders for parenteral administration.
    Jaehnke RW; Kreuter J; Ross G
    J Parenter Sci Technol; 1990; 44(5):282-8. PubMed ID: 2250205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Safety of drugs: problems concerning container closures made of elastomer material for powdered and injectable drugs].
    Colombo A; Zoni G
    Boll Chim Farm; 1977 Nov; 116(11):635-6. PubMed ID: 615637
    [No Abstract]   [Full Text] [Related]  

  • 29. Industry perspective on a holistic container closure integrity approach to parenteral combination products.
    Wuchner K; Brown HC; Canal F; Bonvin D; Goldhammer C; Hebting H; Huon C; Kuhn SM; Mudumala PR; Neuhold K; Riesop D; Steffen JS; Woelfle F
    Eur J Pharm Biopharm; 2024 Jan; 194():20-35. PubMed ID: 37981109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nationwide epidemic of septicemia caused by contaminated intravenous products: mechanisms of intrinsic contamination.
    Mackel DC; Maki DG; Anderson RL; Rhame FS; Bennett JV
    J Clin Microbiol; 1975 Dec; 2(6):486-97. PubMed ID: 1206107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Introducing the Alba® Primary Packaging Platform. Part 2: Inorganic Extractables Evaluation.
    Chillon A; Zuccato D
    PDA J Pharm Sci Technol; 2019; 73(3):235-246. PubMed ID: 30651335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancing Patient Safety through the Use of a Pharmaceutical Glass Designed To Prevent Cracked Containers.
    Schaut RA; Hoff KC; Demartino SE; Denson WK; Verkleeren RL
    PDA J Pharm Sci Technol; 2017; 71(6):511-528. PubMed ID: 28928290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Creating a Holistic Extractables and Leachables (E&L) Program for Biotechnology Products.
    Li K; Rogers G; Nashed-Samuel Y; Lee H; Mire-Sluis A; Cherney B; Forster R; Yeh P; Markovic I
    PDA J Pharm Sci Technol; 2015; 69(5):590-619. PubMed ID: 26429108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Vial Container Closure System Performance Optimization Case Study Using Comprehensive Dimensional Stack-Up Analyses.
    Bucci A; Ho L; Orme L; Zeng Q
    PDA J Pharm Sci Technol; 2020; 74(4):368-376. PubMed ID: 32060224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of current compendial physiochemical test procedures for pharmaceutical elastomeric closures and development of an improved HPLC procedure.
    Milano CJ; Bailey LC
    PDA J Pharm Sci Technol; 1999; 53(4):202-10. PubMed ID: 10754713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Materials for closures of infusion containers].
    Brinkhoff O
    Klin Anasthesiol Intensivther; 1977; (14):46-53. PubMed ID: 926690
    [No Abstract]   [Full Text] [Related]  

  • 37. The pharmaceutical vial capping process: Container closure systems, capping equipment, regulatory framework, and seal quality tests.
    Mathaes R; Mahler HC; Buettiker JP; Roehl H; Lam P; Brown H; Luemkemann J; Adler M; Huwyler J; Streubel A; Mohl S
    Eur J Pharm Biopharm; 2016 Feb; 99():54-64. PubMed ID: 26654992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrity testing of vial closure systems used for parenteral products.
    Frieben WR; Folck RJ; Devisser A
    J Parenter Sci Technol; 1982; 36(3):112-6. PubMed ID: 7097453
    [No Abstract]   [Full Text] [Related]  

  • 39. Container-content compatibility studies: a pharmaceutical team's integrated approach.
    Laschi A; Sehnal N; Alarcon A; Barcelo B; Caire-Maurisier F; Delaire M; Feuilloley M; Genot S; Lacaze C; Pisarik L; Smati C
    PDA J Pharm Sci Technol; 2009; 63(4):285-93. PubMed ID: 20088243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silicone absorption of elastomeric closures--an accelerated study.
    Degrazio FL; Hlobik T; Vaughan S
    PDA J Pharm Sci Technol; 1998; 52(1):19-22. PubMed ID: 9542410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.